Lucrezia Camicia

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2026

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape.

Behind the scenes: how the EMILIN/Multimerin family shapes the cancer landscape.

Journal: The FEBS journal

Published: June 28, 2025

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 02, 2024

The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature.

The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature.

Journal: Frontiers in immunology

Published: August 01, 2023

Emilin2 fosters vascular stability by promoting pericyte recruitment.

Emilin2 fosters vascular stability by promoting pericyte recruitment.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: April 21, 2023

Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway.

Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 27, 2021

The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2.

The Efficacy of Anti-PD-L1 Treatment in Melanoma Is Associated with the Expression of the ECM Molecule EMILIN2.

Journal: International journal of molecular sciences

Published: May 20, 2021

ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers.

ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers.

Journal: Cancers

Published: March 31, 2021

Multimerin-2 orchestrates the cross-talk between endothelial cells and pericytes: A mechanism to maintain vascular stability.

Multimerin-2 orchestrates the cross-talk between endothelial cells and pericytes: A mechanism to maintain vascular stability.

Journal: Matrix biology plus

Published: March 22, 2021

OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence.

OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence.

Journal: Cancers

Published: February 15, 2021

BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells.

BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells.

Journal: Cancer letters

Published: January 17, 2020

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines.

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines.

Journal: Journal of cancer research and clinical oncology

Published: September 07, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026